Klaus LueckeM.Sc, Ph.D, CEO

Founded Haimachek based on ideas generated over the course of his business life. Before commencing the Company’s activities, Dr. Luecke was founder and Managing Director of Infineon Technologies Orion GmbH, a subsidiary of Infineon Technologies AG, a technology company involved in the development of nano chips used in 3G base stations for five years. Previously, Dr. Lücke held senior managerial positions within Infineon Technologies, Siemens Group, and Bell Labs (currently Lucent Technologies) in Germany and the USA. He studied Physics at the Freie Universität Berlin, Germany and was a scientific researcher in the Chemistry Department for Laser Spectroscopy at Rice University, Houston. Dr. Luecke has nearly two decades of experience demonstrating entrepreneurial leadership and successfully transforming innovative technology ideas into commercial opportunities.
Dave S. B. HoonM.Sc, Ph.D, CTO

PROFESSOR, DIRECTOR DEPT MOLECULAR ONCOLOGY AND SEQUENCING CENTER, CHIEF OF SCIENTIFIC INTELLIGENCE at the John Wayne Cancer Institute since 1988. He collaborates with external academic, industry, government agencies, and international cancer centers to develop innovative translational research opportunities. He has coauthored more than 300 peer-reviewed articles and reviews, primarily related to translational molecular oncology of human solid tumors, and has over 25 patents on his studies. As founding Director of the Department of Molecular Oncology (1997), Dr. Hoon continues to pioneer investigations of RNA/ genomic/ epigenomic biomarkers for diagnostic, prognostic and predictive assessment of residual tumor cells. Dr. Hoon had a postdoctoral fellowship at the UCLA School of Medicine within the division of surgical oncology, department of surgery. He completed his Ph.D. in TUMOR METASTASIS AND IMMUNITY University of Saskatchewan in Canada 1983.
Timothy WilsonM.D., Director Clinical Affairs

A board-certified urologist who has vast experience with minimally invasive, laparoscopic and robotic-assisted urologic oncology. He is one of the top six surgeons in the world in terms of volume, that performs robotic-assisted laparoscopic prostatectomy. Dr. Wilson is a member of the American Urological Association and the Society of Urologic Oncology. Throughout his tenure that spans nearly 30 years, he has published numerous peer-reviewed articles and book chapters in the areas of urologic oncology, urinary reconstruction and robotic surgery. In 1995, Los Angeles magazine deemed him one of 25 “Doctors who are making a difference,” and in 1998, he was voted “Professor of the Year” by urology residents in training at the University of Southern California School of Medicine. Dr. Wilson's medical philosophy is to provide safe treatments to patients that can not only cure their cancer, but minimize complications, pain and suffering.
Bryant K. IsaacsMSEE, MBA, Director, and COO

Former President and General Manager of ARRIS’ Assurance Solutions Business Unit, Mr Isaacs also served as President of the Media and Communications Systems BU, New Business Ventures BU, Network Technologies BU, and as an Executive Officer during his tenure at ARRIS. Prior to ARRIS Mr. Isaacs held a variety of executive management positions at Bell Laboratories and General Instrument. Mr. Isaacs holds Masters and Bachelors degrees in Electrical Engineering from Cornell University and Rensselaer Polytechnic Institute respectively. He also holds a Masters in Business Administration from Emory University and was inducted into the Beta Gamma Sigma international honor society in recognition of his academic achievements in the study of business.
Gaines CarterBS, JD., General Counsel and Director

Currently an active member of both the Georgia and Michigan bars and a registered patent attorney with the USPTO. In prior private practice Mr. Carter specialized in Intellectual Property law (patent and trademark prosecution and litigation. As a corporate attorney, he has handled litigation, intellectual property matters, contracts for manufacturing, sales and real estate and has been involved with all all aspects of corporate acquisitions and divestitures. Prior to practicing law, Mr. Carter spent 11 years as an engineer designing network operating systems and then at Stanford Research Institute as a consultant working for governments and private industries. For HaimaChek, Mr. Carter handles a variety of corporate matters including governance, compliance, legal entity management and certain intellectual property matters.